Return to Home Incidence > Table

Incidence Rates Table

Data Options
Comparison Options

Incidence Rate Report by State

Ovary (Late Stage^), 2018-2022

All Races (includes Hispanic), Female, All Ages

Sorted by Count

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count ascending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 6.7 (6.7, 6.8) N/A 14,193 69.0
California 7 7.6 (7.4, 7.8) 3 (1, 8) 1,766 72.7
Florida 2 7.0 (6.8, 7.2) 9 (5, 22) 1,127 67.2
Texas 7 6.8 (6.6, 7.0) 18 (8, 27) 1,075 65.4
New York 7 7.6 (7.4, 7.9) 2 (1, 8) 1,004 72.2
Pennsylvania 2 6.9 (6.7, 7.2) 13 (5, 27) 628 68.9
Illinois 7 6.9 (6.7, 7.2) 14 (6, 27) 563 69.3
Ohio 2 6.3 (6.0, 6.6) 30 (20, 41) 498 66.9
New Jersey 7 7.6 (7.2, 7.9) 4 (1, 11) 461 70.6
Georgia 7 7.0 (6.7, 7.3) 8 (4, 25) 454 73.9
Michigan 2 6.7 (6.4, 7.0) 22 (8, 32) 448 72.0
North Carolina 2 6.2 (5.9, 6.5) 34 (23, 44) 417 69.5
Washington 1 7.0 (6.6, 7.3) 12 (4, 28) 327 73.3
Massachusetts 2 6.8 (6.5, 7.2) 17 (5, 30) 325 73.9
Virginia 2 5.8 (5.5, 6.1) 44 (32, 49) 315 66.6
Arizona 2 6.6 (6.3, 7.0) 23 (8, 36) 306 67.6
Indiana 2 6.9 (6.5, 7.3) 15 (4, 30) 291 70.7
Tennessee 2 6.2 (5.9, 6.5) 33 (21, 45) 274 66.7
Maryland 2 6.5 (6.2, 6.9) 25 (9, 39) 266 68.6
Wisconsin 2 6.8 (6.4, 7.2) 19 (5, 33) 265 68.7
Missouri 2 6.1 (5.7, 6.5) 36 (21, 47) 244 68.8
Colorado 2 6.4 (6.0, 6.8) 29 (12, 42) 217 68.3
Minnesota 2 5.7 (5.4, 6.1) 45 (30, 50) 205 61.8
Alabama 2 5.8 (5.5, 6.2) 41 (27, 49) 201 62.9
South Carolina 2 5.5 (5.1, 5.9) 48 (36, 51) 192 68.0
Oregon 2 6.5 (6.1, 7.0) 27 (8, 42) 181 70.9
Connecticut 7 7.2 (6.7, 7.7) 7 (1, 28) 180 76.4
Louisiana 7 5.9 (5.5, 6.4) 40 (24, 49) 174 71.5
Kentucky 7 5.8 (5.4, 6.3) 42 (26, 50) 168 68.9
Oklahoma 2 6.8 (6.3, 7.3) 20 (4, 37) 163 67.3
Iowa 7 7.0 (6.5, 7.5) 11 (1, 33) 145 73.7
Arkansas 2 6.5 (6.0, 7.0) 26 (6, 44) 126 66.5
Nevada 2 6.2 (5.7, 6.8) 32 (10, 48) 116 60.8
Utah 7 7.5 (6.9, 8.1) 5 (1, 26) 115 74.8
Puerto Rico 2 4.8 (4.4, 5.2) N/A 114 64.4
Kansas 2 6.0 (5.5, 6.6) 38 (16, 49) 110 69.6
Mississippi 2 5.2 (4.7, 5.7) 50 (39, 51) 101 67.7
West Virginia 2 7.2 (6.5, 8.0) 6 (1, 34) 90 64.5
Idaho 7 7.9 (7.1, 8.7) 1 (1, 21) 87 76.5
New Mexico 7 6.0 (5.4, 6.7) 39 (13, 50) 83 66.7
Nebraska 2 6.1 (5.4, 6.8) 37 (10, 50) 70 69.3
New Hampshire 2 7.0 (6.2, 7.8) 10 (1, 42) 68 69.0
Hawaii 7 5.8 (5.1, 6.6) 43 (12, 51) 53 64.3
Delaware 2 6.9 (6.0, 7.9) 16 (1, 46) 50 71.1
Montana 2 6.8 (5.9, 7.7) 21 (1, 47) 50 66.1
Maine 2 4.9 (4.3, 5.7) 51 (37, 51) 49 62.1
Rhode Island 2 5.6 (4.8, 6.4) 46 (19, 51) 43 63.6
South Dakota 2 6.3 (5.3, 7.3) 31 (2, 51) 35 68.6
Vermont 2 6.5 (5.5, 7.8) 24 (1, 51) 28 67.9
North Dakota 2 5.4 (4.4, 6.5) 49 (11, 51) 24 69.7
District of Columbia 2 6.2 (5.1, 7.4) 35 (1, 51) 23 57.9
Alaska 2 6.5 (5.3, 7.8) 28 (1, 51) 23 71.5
Wyoming 2 5.5 (4.4, 6.7) 47 (6, 51) 20 67.3

Notes:
Created by statecancerprofiles.cancer.gov on 03/29/2026 7:31 pm.

State Cancer Registries may provide more current or more local data.

Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.


† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

2 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

7 Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.

Return to Top